Φορτώνει......
Improved prognosis in gastric adenocarcinoma among metformin users in a population-based study
BACKGROUND: Metformin may improve the prognosis in gastric adenocarcinoma, but the existing literature is limited and contradictory. METHODS: This was a Swedish population-based cohort study of diabetes patients who were diagnosed with gastric adenocarcinoma in 2005–2018 and followed up until Decemb...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Br J Cancer |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Nature Publishing Group UK
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8292480/ https://ncbi.nlm.nih.gov/pubmed/33972744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-021-01408-8 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|